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Background: Adenosine receptors (ARs) belong to the G protein-coupled receptors (GCPRs) family. The recent
release of X-ray structures of the human A2A AR (h A2A AR ) in complex with agonists and antagonists has increased
the application of structure-based drug design approaches to this class of receptors. Among them, homology
modeling represents the method of choice to gather structural information on the other receptor subtypes, namely
A1, A2B, and A3 ARs. With the aim of helping users in the selection of either a template to build its own models or
ARs homology models publicly available on our platform, we implemented our web-resource dedicated to ARs,
Adenosiland, with the “Best Template Searching” facility. This tool is freely accessible at the following web address:
http://mms.dsfarm.unipd.it/Adenosiland/ligand.php.
Findings: The template suggestions and homology models provided by the “Best Template Searching” tool are
guided by the similarity of a query structure (putative or known ARs ligand) with all ligands co-crystallized with
hA2A AR subtype. The tool computes several similarity indexes and sort the outcoming results according to the
index selected by the user.
Conclusions: We have implemented our web-resource dedicated to ARs Adenosiland with the “Best Template
Searching” facility, a tool to guide template and models selection for hARs modelling. The underlying idea of our
new facility, that is the selection of a template (or models built upon a template) whose co-crystallized ligand
shares the highest similarity with the query structure, can be easily extended to other GPCRs.
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The template suggestions and homology models pro-
vided by the “Best Template Searching”tool are guided
by the similarity of a query structure (putative or known
ARs ligand) with all ligands co-crystallized with hA2A
AR subtype. The tool computes several similarity
indexes and sort the outcoming results according to the
index selected by the user.Background
Adenosine receptors (ARs) belong to the G protein-
coupled receptors (GCPRs) family. The known four
subtypes, termed adenosine A1, A2A, A2B and A3 receptors,
are widely distributed in human body and involved in* Correspondence: stefano.moro@unipd.it
2Molecular Modeling Section (MMS), Department of Pharmaceutical and
Pharmacological Sciences, University of Padova, via Marzolo 5, I-35131
Padova, Italy
Full list of author information is available at the end of the article
© 2013 Floris et al.; licensee Springer. This is an
Attribution License (http://creativecommons.or
in any medium, provided the original work is pseveral physio-pathological processes (Fredholm et al.
2001). The release of X-ray structures of the human A2A
AR in complex with agonists (Lebon et al. 2011, Xu et al.
2011) and antagonists (Jaakola et al. 2008, Doré et al. 2011,
Hino et al. 2012, Congreve, et al. 2012, Liu, et al. 2012) has
enabled to extend structure-based drug design approaches
to this class of receptors. With the use of homology model-
ling techniques, indeed, structural information on the
other subtypes can also be derived. As a key step when
building homology models is the selection of a proper
template, we have developed a tool to guide the user in this
crucial choice by implementing the “Best Template
Searching” facility in our web-resource dedicated to ARs,
Adenosiland (Floris et al. 2013). This tool is freely access-
ible at the following web address: http://mms.dsfarm.
unipd.it/Adenosiland/ligand.php.
The underlying idea behind this facility is to help the
user in selecting the best template or ARs model to get
the highest quality receptor for further molecularOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Values of the in-house validation of the combined
similarity index
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http://www.in-silico-pharmacology.com/content/1/1/25docking studies. A possible strategy herein presented is
to compute the similarity between a known or putative
agonist/antagonist and all co-crystallized ARs ligands.
Tool description
The “Best Template Searching” tool works as follows:
the user is asked to input a query molecule either by
uploading a SMILES string or by directly drawing the
2D structure by using the JME interface; the similarity of
the input molecule is then computed against all the
ligands co-crystallized with the hA2A AR. The following
similarity indexes are calculated: (i) shape similarity
(based on the Manhattan distance between USR descrip-
tors), (ii) 2D similarity (based on the Tanimoto and
Tversky Similarities of Pubchem Fingerprints), (iii) phar-
macophoric similarity (based on the Tanimoto similarity
of Pharmacophoric triplets), and (iv) a combined similar-
ity (derived by the following function: 0.6 * pharmaco-
phoric similarity + 0.4 * shape similarity).
The values of the two coefficients composing the latter
similarity index have been derived by running a preliminary
in-house validation based on all available crystallographic










T4G 3UZA 0.33 0.86 0.89
ZM 241385 3PWH 0.58 0.90 0.93
T4E 3UZC 0.37 0.84 0.89
ZM 241385 4EIY 0.34 0.90 0.93
ZM 241385 3EML 0.35 0.90 0.93
NECA 2YDV 0.51 0.82 0.87
ZM 241385 3VG9 0.32 0.90 0.93
XAC 3REY 0.21 0.89 0.94
ZM 241385 3VGA 0.28 0.90 0.93
Adenosine 2YDO 0.33 0.82 0.86
Caffeine 3RFM 0.26 0.81 0.85
UK-432,097 3QAK 0.16 0.87 0.93so that by providing as input the structures of the co-
crystallized ligand the corresponding receptor structure
results the best ranked one according to the combined
similarity index. The values obtained for the structures
considered for the internal validation are reported in
Table 1. For all the structure except one, the suggested
template results the corresponding crystal structure. The
only exception is represented by NECA for which the
structure co-crystallized with adenosine is suggested as
best template. Considering the high structural similarity
between the two agonist structures, the results is in line
with the others.
Simultaneously to the best template searching process, a
similarity search screening is also performed against all
adenosine agonists and antagonists deposited in ChEMBL,
release 14 (Gaulton et al. 2011). In more details, the query
is compared to 760 A1, 469 A2A, 559 A2B and 290 A3 AR
ligands and the comparison is based on the calculation of
the similarity measures previously described. The identi-
fied compounds are reported in a table along with the
associated binding data available in literature.
Tool validation
Ligand similarity biased template selection criteria at the
basis of the “Best Template Searching” tool has been
successfully applied to rationalize the Structure Activity
Relationships (SAR) of a series of [5-substituted-4-
phenyl-1,3-thiazol-2-yl] furamides as antagonist of the
hARs (Inamdar et al. 2013). The most potent derivative
of the furamides series, the furan-2-carboxylic acid (4-
phenyl-5-pyridin-4-yl-thiazol-2-yl)-amide, has been selec-
ted as query molecule: As reported in Table 2, a similarity
sorting of the templates based on the combined similarity
criteria has been taken into account to select the most suit-
able models for receptor-based ligand design. The selected



















Figure 1 Workflow of the homology modeling template selection based on the structure of furan-2-carboxylic acid (4-phenyl-5-
pyridin-4-yl-thiazol-2-yl)-amide.
Floris et al. In Silico Pharmacology 2013, 1:25 Page 3 of 4
http://www.in-silico-pharmacology.com/content/1/1/25suggested best template, namely the structure with the
3UZA PDB ID, co-crystallized with the 6-(2,6-dimethylpyr-
idin-4-yl)-5-phenyl-1,2,4-triazin-3-amine (T4G), we have
constructed A1, A2B and A3 AR models through homology
modeling and used the so derived structural information to
provide hypotheses of ligand-receptor interaction and
ligand-receptor selectivity profile (Inamdar et al. 2013).
Methods
The “Best Template Searching” tool is part of the
Adenosiland infrastructure, based on Ubuntu 9.10 Linux
operating system, which is a patchwork of several in-
formatics tools (for more details see Floris et al. 2013).
The similarity indexes are calculated by using different
approaches: 2D similarity based on Tanimoto and
Tversky indexes (Steinbeck et al. 2003, 2006) are calcu-
lated from Pubchem Fingerprints (CDK implementation),
the shape similarity is calculated by using an in-house im-
plementation of the Ultrafast Shape Recognition method
(Floris et al. 2011, Ballester and Richards 2007), and the
pharmacophoric features of the pharmacophore-based
similarity index are described by Gaussian 3D volumes
(Taminau et al. 2008).
Conclusions
We have implemented a novel tool, called “Best
Template Searching” to provide template suggestions
and homology models of all four hARs based on the
similarity between a query structure provided by the
user and all co-crystallized ARs ligands. It is well known
that ligand-driven induced fit of the receptor is a key
feature to facilitate the identification or the optimization
of novel potent and selective agonists and antagonists, in
particular through molecular docking studies. We
therefore believe that choosing as template the structure
co-crystallized with the ligand that shares the highest
structural similarity with the scaffold of interest may
represent an effective strategy. This is in facts the under-
lying idea of our platform implementation: By using the“Best Template Searching” option, users can upload a
SMILES string or directly draw the 2D structure by
using the JME interface of the scaffold of interest and
search the most similar ligand co-crystallized so far with
the hA2A AR. Several similarity indexes are calculated by
using different approaches such as a 2D similarity,
shape similarity, pharmacophore-based similarity, and
simple consensus shape- and pharmacophore-based
similarity index.
We are also confident that the proposed strategy can
be easily and effectively extended to other GPCRs.
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